Doctor profile · Federal record
Dr. Max Benzaquen, MD
Neurology Physician · Chesterfield, MO
- NPI 1366426900
- MIPS 0.0 / 100 · 2023
- 21 yrs on file
- Male
- Solo practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
14377 Woodlake Dr Ste 308
Chesterfield, MO 630175735
(314) 878-8744
fax (314) 878-2234 - Additional location
-
224 South Woods Mill Road, Suite 290 South
Chesterfield, MO 630173451
Credentials & registration
- NPI registered
- December 2005 — 21 yrs on file
- Profile last updated
- June 19, 2025
- Specialty taxonomy
- 2084N0400X — NUCC code
- State license (1)
- Missouri #100507
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1366426900. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
705
Distinct HCPCS
2
Medicare allowed
$88,223
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 669 | 304 | $123 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 36 | 36 | $162 |
In context: peer comparison
Among 4 peers in Chesterfield Neurology Physician, average services per provider: 241. This provider delivers 2.9× the peer median.Open Payments
Industry payments received
All-time total
$8,059
Transactions
271
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | 24 | $745.37 | |
| Abbvie INC. | 31 | $563.01 | |
| Neurocrine Biosciences, INC. | 17 | $476.73 | |
| Csl Behring | 13 | $455.14 | |
| Ucb, INC. | 23 | $454.87 | |
| Otsuka America Pharmaceutical, INC. | 16 | $435.61 | |
| Pfizer INC. | 35 | $378.54 | |
| Vanda Pharmaceuticals INC. | 15 | $378.44 | |
| Harmony Biosciences LLC | 13 | $347.19 | |
| Teva Pharmaceuticals USA, INC. | 15 | $268.96 | |
| Novartis Pharmaceuticals Corporation | 19 | $249.43 | |
| Lundbeck LLC | 10 | $246.54 | |
| Neurelis, INC. | 15 | $227.77 | |
| Supernus Pharmaceuticals, INC. | 13 | $217.95 | |
| Acadia Pharmaceuticals INC | 12 | $204.22 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,313
Patients
567
Total drug cost
$82,562
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Carbidopa-Levodopa (Carbidopa/Levodopa) | Brand | 290 | 64 | $16,573 |
| Clonazepam | Generic | 236 | 36 | $1,459 |
| Duloxetine Hcl | Generic | 218 | 36 | $5,273 |
| Gabapentin | Generic | 208 | 55 | $7,146 |
| Memantine Hcl ER (Memantine Hcl) | Brand | 162 | 36 | $25,375 |
| Methylprednisolone Acetate | Generic | 156 | 82 | $3,056 |
| Primidone | Generic | 152 | 31 | $3,906 |
| Levetiracetam | Generic | 134 | 33 | $7,353 |
| Tramadol Hcl | Generic | 132 | 27 | $1,897 |
| Memantine Hcl | Generic | 128 | 40 | $2,628 |
Frequently asked questions
What is Dr. Max Benzaquen's medical specialty?
Dr. Max Benzaquen practices Neurology Physician in Chesterfield, MO.
Where does Dr. Max Benzaquen practice?
Dr. Max Benzaquen practices at 14377 Woodlake Dr Ste 308, Chesterfield, MO 630175735. Office phone: 3148788744.
What is Dr. Max Benzaquen's NPI?
Dr. Max Benzaquen's National Provider Identifier (NPI) is 1366426900, issued by NPPES.
What procedures does Dr. Max Benzaquen commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); New patient office or other outpatient visit (HCPCS 99204). Source: CMS Medicare Physician & Other Practitioners file.